83560 Federal Register / Vol. 88, No. 229 / Thursday, November 30, 2023 / Notices 

Dated: November 24, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–26358 Filed 11–29–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meetings of the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that a virtual meeting is scheduled to be 

held for the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria (PACCARB). The 

meeting will be open to the public and 

will be streamed live on hhs.gov/live. A 

pre-registered public comment session 

will be held during the meeting. Preregistration is required for members of 

the public who wish to present their 

comments live during the virtual 

meeting. Individuals who wish to 

provide written public comment should 

send an email to CARB@hhs.gov that 

includes their written comments. 

Registration information is available on 

the website http://www.hhs.gov/paccarb 

and should be completed by December 

18, 2023 for the December 20, 2023 

virtual Public Meeting. Additional 

information about registering for the 

meeting and providing public comment 

can be obtained at http://www.hhs.gov/ 

paccarb on the Upcoming Meetings 

page. HHS is also giving notice of the 

appointment of 16 new PACCARB 

councilmembers that will be sworn-in 

in preparation of the December 20, 2023 

virtual public meeting. 

DATES: The meeting is scheduled to be 

held on December 20, 2023, from 9 a.m. 

to 4 p.m. ET (times are tentative and 

subject to change). The confirmed times 

and agenda items for the meeting will be 

posted on the website for the PACCARB 

at http://www.hhs.gov/paccarb when 

this information becomes available. Preregistration for attending the meeting is 

strongly suggested and should be 

completed no later than December 18, 

2023. 

ADDRESSES: The virtual meeting can be 

accessed through a live webcast on the 

day of the meeting. Additional 

instructions regarding attending this 

meeting virtually will be posted at least 

one week prior to the meeting at: http:// 

www.hhs.gov/paccarb. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, 1101 Wootton Parkway, 

Rockville, MD 20852. Phone: 202–746– 

1512; Email: CARB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the PACCARB are governed by 

the provisions of the Federal Advisory 

Committee Act (FACA), Public Law 92– 

463, as amended (5 U.S.C. app.), which 

sets forth standards for the formation 

and use of federal advisory committees. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary of 

Health and Human Services (Secretary) 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: the effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The Advisory Council is authorized to 

consist of at least 30 members, 

including the voting and non-voting 

members and the Chair and Vice Chair. 

The current composition of the 

Advisory Council consists of 15 voting 

members, including the Chair and Vice 

Chair, eight non-voting liaison 

representative members, and 12 nonvoting ex-officio members. In March of 

2023, the terms of 16 councilmembers 

ended, and an announcement was 

published August 1, 2022 and closed on 

September 19, 2022 to solicit 

nominations to fill the open PACCARB 

positions, nine of which were in the 

voting member category, including the 

Chair and Vice-Chair positions, while 

the remaining seven were in the nonvoting liaison member category. These 

positions have been filled and the new 

PACCARB members will be sworn-in in 

preparation for the December 20, 2023, 

virtual public meeting. Newly 

appointed voting members were 

selected to serve four-year terms, and 

non-voting liaison members were 

appointed to serve for two-year terms. 

The full roster of councilmembers, 

including the 16 new members, can be 

found on the Membership page at http:// 

www.hhs.gov/paccarb. 

The December 20, 2023, virtual public 

meeting will be dedicated to current 

global U.S. federal efforts to combat 

antimicrobial resistance in response to a 

task from the Secretary given to the 

PACCARB in 2023. The signed task 

letter from the Secretary can be found at 

http://www.hhs.gov/paccarb. The 

meeting agenda will be posted on the 

PACCARB website at http://

www.hhs.gov/paccarb when it has been 

finalized. All agenda items and times 

are tentative and subject to change. 

Instructions regarding attending the 

meeting virtually will be posted at least 

one week prior to the meeting at: http:// 

www.hhs.gov/paccarb. 

Members of the public will have the 

opportunity to provide comments 

during the December meeting by preregistering online at http://

www.hhs.gov/paccarb. Pre-registration 

is required for participation in this 

session with limited spots available. 

Written public comments can also be 

emailed to CARB@hhs.gov by midnight 

December 18, 2023 and should be 

limited to no more than one page. All 

public comments received prior to 

December 18, 2023, will be provided to 

the PACCARB members. Additionally, 

companies and/or organizations 

involved in combating antibiotic 

resistance have an opportunity to 

present their work to members of the 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 229 / Thursday, November 30, 2023 / Notices 83561 

PACCARB live during an Innovation 

Spotlight. Pre-registration is required for 

participation, with limited spots 

available. All information regarding this 

session can also be found online at 

http://www.hhs.gov/paccarb. 

Dated: November 9, 2023. 

Jomana F. Musmar, 

Designated Federal Officer, Presidential 

Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2023–26320 Filed 11–29–23; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Instrumentation, Assay 

Development and Cellular Biology. 

Date: December 15, 2023. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joonil Seog, SCD Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, 301–402–9791, 

joonil.seog@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 24, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–26264 Filed 11–29–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Time-Sensitive 

Obesity Review. 

Date: December 18, 2023. 

Time: 3:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

Division of Extramural Activities, NIDDK, 

National Institutes of Health, Room 7353, 

6707 Democracy Boulevard, Bethesda, MD 

20892–2542, (301) 594–8898, barnardm@

extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 27, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–26361 Filed 11–29–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket Number: USCG–2023–0825] 

Designation of the Coast Guard 

Academy Athletics Corporation as a 

Qualified Organization and 

Appointment of Dr. Daniel Rose as a 

Member of the Board of Directors of 

the Corporation 

AGENCY: Coast Guard, Department of 

Homeland Security (DHS). 

ACTION: Notice. 

SUMMARY: The Coast Guard announces 

the designation of the Coast Guard 

Academy Athletics Corporation 

(CGAAC) as a qualified non-Federal 

entity that can receive support from the 

Federal Government. Dr. Daniel Rose, 

Athletics Director of the Coast Guard 

Academy, has been appointed to serve 

as a member on the Board of Directors 

of the CGAAC. Dr. Rose will provide 

oversight of, advice to, and coordination 

with, the CGAAC. Dr. Rose will not 

participate in the day-to-day operations 

of the CGAAC. 

DATES: The appointment was made 

October 19, 2023. 

ADDRESSES: To view documents 

mentioned in this preamble as being 

available in the docket, go to https://

www.regulations.gov, type USCG–2023– 

0825 in the search box and click 

‘‘Search.’’ Next, in the Document Type 

column, select ‘‘Supporting & Related 

Material.’’ 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this rule, call or 

email Commander Jeffrey G. Janaro, 

Coast Guard Academy, telephone 860– 

444–8255, email jeff.g.janaro@uscg.mil. 

SUPPLEMENTARY INFORMATION: The Coast 

Guard announces the designation of the 

Coast Guard Academy Athletics 

Corporation (CGAAC) as a ‘‘qualified 

organization’’ under 14 U.S.C. 953. 

Section 953 allows the Coast Guard 

Academy Alumni Association to 

establish a ‘‘qualified organization’’ 

solely for the purpose of supporting 

Coast Guard athletics. 

A ‘‘qualified organization’’ means an 

organization (1) that operates as an 

organization under subsection (c)(3) of 

section 501 of the Internal Revenue 

Code of 1986 and exempt from taxation 

under subsection (a) of that section; (2) 

for which authorization under sections 

1033(a) and 1589(a) of Title 10 may be 

provided; and (3) established by the 

Coast Guard Academy Alumni 

Association solely for the purpose of 

supporting Coast Guard athletics. 


khammond on DSKJM1Z7X2PROD with NOTICES